APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Apimeds Pharmaceuticals US, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.50−0.54 (-13.37%)
Close on Oct 19, 2026
- Market cap
- $6.00M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Apimeds Pharmaceuticals US has not reported a dividend
No dividend per share appears in Apimeds Pharmaceuticals US's annual filings since fiscal 2022.